Tap icon
to view sections

Objectives

The following module was designed to supplement learning in the clinic. Please take the time to read through each section by clicking the headings below. By the end of the module, the following objectives should be addressed:

  1. Acquire a foundational overview of at-home palliative care
  2. Understand when community palliative care is appropriate and recognize factors that suggest against at-home palliative care
  3. Understand the principles of de-prescribing and anticipatory prescribing to support patients passing away at home
  4. Describe the general principles of Advance Care Planning 
  5. Understand the importance of interdisciplinary care and the roles of various interdisciplinary team members providing at-home palliative care
  6. Recognize the stages of dying and common oncologic emergencies

What is Palliative Care

Palliative care focuses on improving comfort, quality of life, and overall well-being for individuals living with serious illness, while also supporting their caregivers. The aim is to relieve physical symptoms such as pain, nausea, fatigue, and shortness of breath, as well as addressing emotional, psychological, social, cultural, and spiritual needs of patients and their loved ones [1].

Across Canada, palliative care can be provided in a variety of settings, including hospitals, palliative care units, long-term care facilities, hospices, clinics, and patients’ homes. While the majority of Canadians would prefer to pass away at home, only about 15% have access to palliative home care services [1]. At the same time, relatively few health care providers in Canada specialize in or practice primarily community palliative care [1]. To promote broader awareness of home-based palliative care, this module provides a foundational overview of several key components including goals of care discussions, interdisciplinary support, symptom management, and end-of-life care.

Approaching the Home

How to Make the Decision for At-Home Palliative Care

The decision to begin palliative care is made collaboratively by medical professionals and the patient. Depending on discussions with their provider about goals of care, a transition to an at-home palliative care approach may be the most appropriate option [1]. For oncology patients, some situations in which a provider may recommend community palliative care include:

  • The cancer is found to be life-limiting and is causing significant functional decline
  • The patient is too frail to undergo systemic therapy
  • The disease has progressed despite ongoing therapy, as shown by imaging, biochemistry, and/or pathology

Complex cases may be brought to multidisciplinary tumour boards, which reach a consensus on whether further treatment options exist. Regardless, patients may benefit from palliative care involvement whether or not they are receiving therapeutic care, even when further treatment options are available. In fact, palliative care can be provided concurrently with therapeutic treatments, particularly to help patients with symptom management and/or functioning. 

As a patient’s care begins moving from outpatient oncology appointments to home-based palliative care, it is prudent to refer them to a community palliative care nursing team and/or a community palliative care physician. Early referral has been shown to improve quality of life and mood, and to make it more likely that a patient’s end-of-life preferences are identified [2]. 

Managing Conversations about Palliative Care

When a healthcare provider has identified a patient who may need to transition from curative treatment to a primarily palliative approach to care, they may opt to discuss this with the patient at a dedicated appointment. Inviting the patient’s support system, including their substitute decision maker, is important when discussing illness understanding and goals of care. The Serious Illness Conversation Guide provides a structure to initiate and facilitate this conversation where the provider: asks permission, assesses what the patient understands and wants to know, shares their prognosis, explores patient goals and fears for the future, and closes by summarizing the situation and making a recommendation for next steps [1]. It should also be determined if at-home palliative care is practical, safe, and appropriate, which is discussed further below. Next steps commonly include a referral to specialized palliative care services, request for transfer to a palliative care facility, or a referral to home-based care. It is important to remember that a patient may not feel prepared to pursue palliative care after the initial conversation. In these cases, it is important to make the patient feel supported, explore their expectations and goals for the future, and continue working with them while establishing the possibility of initiating another conversation regarding palliative care in the future.

Certain patients may benefit from goal setting during a serious illness conversation as it may provide a sense of control and help them stay focused on what matters to them. Thematic domains for goals can include physical wellbeing (going for walks, getting good sleep), psychological wellbeing (engaging with reading, practicing coping skills), social wellbeing (spending time with loved ones, continuing to engage with work, getting their finances in order), and spiritual wellbeing (finding inner strength, connecting with a higher power) [2]. Ultimately the best goal(s) for a patient will be highly personal, though a provider can help patients explore their goals through serious illness conversations.

Evaluating the Home

When a patient expresses a wish to pass away at home, it is important for the provider to evaluate safety and practicality of the home environment based on a number of domains. These domains include the patient’s medical status, functional status, psychologic status, home environment, support network, and access to resources. A brief summary of key points to consider for each domain is outlined in Table 1.

Initial and ongoing documentation of a patient’s functional status is also important to allow for ongoing monitoring of their functional and care needs. Objective tools used to communicate a patient’s function include: the Palliative Performance Status (PPS), which is widely used to communicate function in palliative care; the ECOG scale, commonly used in oncology to communicate functional status in relation to systemic therapy candidacy; and the Karnofsky Performance Status Scale (KPS), used to monitor functional status in relation to disease progression. 

Ultimately, the provider should offer a recommendation, based on their assessment, that clarifies which institutional and/or community environments palliative care be safely delivered in to adequately support patient function and wellbeing. It should also be recognized that these decisions around disposition planning are dynamic and must be revisited on an ongoing basis. For example, a patient who develops worsening symptoms and/or increased care needs not manageable at home may need their care transitioned from home to hospice [1]. Providers should also consider providing referrals to counselling services for patients experiencing major adjustments in their care, as these transitions are often difficult to cope with [2]. Many cancer agencies offer psychiatric services and in-house counselling for patients and their families.

Table 1. Questions to ask when assessing the practicality of at-home palliative care

Advance Care Planning

For patients with progressive disease and a limited prognosis, it is important to discuss preferences for future health and personal care. This process is often called “Advance Care Planning” and it generally has two intentions: 1) Instructional directives that outline what kinds of health care a person does or does not want under particular conditions, 2) Proxy directives that name a representative who will make decisions if the person loses decision-making capacity [1]. While the general principles of Advance Care Planning are similar across Canadian provinces, each province has its own legal structures, terminology, and documents which can vary [1]. It is important for providers to be aware of the specific details for advance care planning in their jurisdiction, and to explore a patient’s goals, wishes, and values to understand how to provide goal-concordant care.

Strategies to Optimize Care

Anticipatory Prescribing

Anticipatory prescribing, an important component of home-based palliative care, involves the proactive practice of prescribing medications for palliative patients to help ease symptoms that can occur in the last few hours or days of life. These symptoms may include pain, agitation, breathlessness, nausea and vomiting, anxiety, delirium, and respiratory secretions [1]. Anticipatory prescriptions include analgesics, antiemetics, antipsychotics, anxiolytics, and anti-secretory agents that nurses, physicians, and trained healthcare providers can administer. Administration may be done with a needle and syringe or a needle-free technique, where the syringe is connected to a pre-existing subcutaneous catheter [2]. At the end-of-life, administration is mostly done with a subcutaneous catheter. In a home setting, these medications along with relevant medical supplies are dispensed and stored in the home in a “symptom management toolkit” so that they are readily available whenever symptoms arise [1]. Examples of these medications are summarized in Table 2. Beyond the use of medications, non-pharmacological interventions are also utilized to promote more effective palliative care. Non-pharmacological interventions for symptom management are outlined in Table 3.

Table 2. Common medications used to help manage symptoms at the end-of-life [3]
Table 3. Non-pharmacological strategies to manage symptoms at the end-of-life [4,5,6]

The Role of De-Prescribing

When caring for a patient whose care is transitioning from primarily oncologic care to primarily palliative care, it is important to consider deprescribing medications that are no longer indicated. Patients with advanced cancer often have a large pill burden, including medications for primary or secondary prevention which may no longer serve a benefit for people with a prognosis of days, weeks, or months [1]. Polypharmacy creates burdens to patients including pill fatigue, cost, and risk of side effects. Deprescribing is the practice of identifying and discontinuing medications with little or no benefit and potential harm, with the goal of improving quality of life [1]. It is typically performed via the following steps:

  • Take a detailed medication history including indication for each drug
  • Consider the potential for drug-induced harm from each drug and overall polypharmacy
  • Consider each individual medication and the potential to provide ongoing benefit
  • Prioritise medications for deprescribing
  • Review deprescribing with the patient, deprescribe prioritized medications, and arrange follow up to monitor

There are also various tools to support deprescribing, with the “OncPal Deprescribing Guideline” being developed to identify potentially inappropriate medicines in the palliative oncology setting [2]. Examples of classes of medications that are appropriate to consider deprescribing include statins and in some cases antihyperglycemics, antihypertensives, gastroprotective medications, and vitamins/supplements [1].

Interdisciplinary Care

Home-based palliative care relies on an interdisciplinary team working together to support the patient and loved ones. The team may include physicians, nurses, social workers, home/personal support workers, volunteers, spiritual care providers, community organizations, and other healthcare professionals [1]. Depending on the region and available services, teams may offer regular home visits and 24/7 on-call support [1]. Table 4 summarizes the roles of some of the community palliative care team members.

Table 4. Members and roles of the community palliative care team [2,3]

Home-based palliative care plays an important role in preserving dignity and autonomy by allowing patients who wish to die at home the opportunity to die in a familiar and comfortable environment while receiving the appropriate care. Health care professionals can support dignity by recognizing both the patient and their loved ones as the unit of care, while ensuring effective symptom management, continuity of care, and respect for individual wishes [4]. The integration of home-based palliative care has been associated with improved quality of life and a greater likelihood of patients dying at home in accordance with their preferences. It may also reduce emergency department visits, healthcare costs, and hospital admission and length of stay [1]. Currently, there are resource limitations to dying at home. In many cases, there is a large reliance on patients’ loved ones to be caregivers, which can lead to burnout. If care needs are too high for caregivers, looking into hospice would be appropriate.

What End of Life in the Home May Look Like

Stages of Dying

The period at which patients receiving palliative care transitions from active participation in activities of daily living to progressive decline of functional and cognitive status, worsening signs/symptoms, and decreased response to treatment is described as the transitional phase of the dying process. When a patient with incurable disease becomes bedbound and dependent on care because of disease progression, this may be followed by accelerated decline and indicate a prognosis of days to weeks [1]. End-of-life involves 3 stages: early, middle, and late. These involve a series of signs and symptoms that may occur as the body shuts peripherally to centrally [2]. 

Early Stage (approximately >7 to 28 days before death)

  • Loss of Mobility: Patients experience worsening weakness leading to more difficulties in ambulation and transferring. They may also experience more difficulties in performing activities of daily living, such as dressing and showering.
  • Decrease in Food Intake: Secondary to loss of appetite/cancer-related anorexia-cachexia syndrome, nausea and vomiting, and/or dysphagia to solid foods
  • Cognitive Changes: Increasing episodes of confusion or delirium (hypoactive or hyperactive), social withdrawal, and/or sleeping more.
  • Pain
  • Dyspnea and/or increased respiratory secretions

Middle Stage (>3 to 7 days before death)

  • Decline in consciousness and mental status: Patients may become slow to rouse to voice and experience increased somnolence/briefer periods of wakefulness. They may be less responsive to visual or verbal stimuli.
  • Agitation or Purposeless Movement
  • Dysphagia to solids and/or liquids
  • Small movements like twitching or jerking
  • Dry mouth
  • Irregular Breathing Pattern
  • Capillary Refill >3 seconds

Late Stage (<1 to 3 days before death)

  • Cheyne-Stokes Breathing: Periods of apnea, hyperpnea, or irregular breathing
  • Death Rattle: Some patients may have noisy breathing from secretions/mucus buildup in the throat and lungs.
  • Mouth Breathing/breathing with mandibular movement during the last hours of life.
  • Peripheral cyanosis: Skin may feel colder, have a blue/purple discoloration, or mottled.
  • Weak radial artery pulse
  • Decreased Urine Output: <200 mL
  • Non-reactive pupils
  • Inability to open eyelids and drooping of nasolabial fold
  • Coma: Patients may be in a state of unconsciousness from which they cannot be roused.
  • Significant drops in baseline blood pressure (systolic <100 mmHg with decrease of >= 20 mmHg and diastolic <60 mmHg with decrease of >= 10 mmHg) and oxygen saturation

Palliative Emergencies

Providers should be aware of medical emergencies that may arise in the palliative setting. When left unnoticed or untreated, it may lead to a poorer quality of life and/or a shortened prognosis. Patients with advanced cancer are at risk of palliative and oncologic emergencies. Management for such may involve home visits and/or presentation to hospital, depending on the person’s goals of care. Clinical decisions should consider patients’ wishes, history and prognosis of the disease, patients’ physical condition, burden and likely outcome of treatment, and symptom burden of the condition [1]. Anticipatory care should also be considered, such as inserting subcutaneous butterflies to allow for a reliable route of administration of crisis medications and/or teaching family/friends/caregivers who are willing how to administer subcutaneous medications in case a nurse/provider is not present in the home

Common emergencies in palliative care include [1, 2] 

  1. Spinal cord compression: A common complication of bone metastases to the vertebrae or spine. This can result in pain, numbness, or loss of bladder and bowel control. The longer the compression persists, the more likely there will be permanent neurologic deficits. Management of suspected cord compression may include dexamethasone, radiation therapy, bowel and bladder care (including insertion of a urinary catheter), and referral to spine surgery for consideration of decompression surgery.
  2. Superior Vena Cava Obstruction (SVCO): More commonly caused by extrinsic compression from a tumour or less commonly from venous thrombosis. Signs and symptoms may include dyspnea, headaches, lightheadedness, and/or facial swelling. Treatment may include dexamethasone to decrease peritumoural edema if extrinsic tumour compression is present, anticoagulation if an occlusive thrombus is present, stent insertion, or radiation therapy.
  3. Massive Hemorrhage/Terminal Bleeding: Certain cancers confer a high bleeding risk due to high vascularity and/or proximity to vasculature. Massive hemorrhage is bleeding that is large in volume and rapid, and in the context of rapidly progressive cancer, may be a terminal bleed. Massive hemorrhage can often be anticipated, and counselling patients and their loved ones about the possibility of a terminal bleeding event and management of such can significantly alleviate stress if or when the event does occur. Management is supportive, involving administration of benzodiazepines such as subcutaneous midazolam for sedation and opioids for comfort. Caregivers are also advised to keep dark towels in the home to use in case of a terminal bleeding event.
  4. Severe Dyspnea: Certain oncologic disease with lung involvement, such as lung cancer or lung metastases, can lead to severe dyspnea when there is significant disease burden. While hypoxia may be treated with supplemental oxygen, dyspnea is the subjective sensation of shortness of breath. Treatment for severe dyspnea at end-of-life generally involves opioids to alleviate the sensation of air hunger. If dyspnea is refractory to opioids, benzodiazepines and/or palliative sedation can be considered.
  5. Acute Venous Thromboembolism (VTE): Incidence of deep vein thrombosis and pulmonary embolism increases with cancer progression and the use of chemotherapy. Thrombotic risk is higher in upper gastrointestinal, pancreatic, lung, and ovarian cancers. Symptoms of pulmonary embolism include dyspnea, pleuritic chest pain, hemoptysis, and/or tachycardia. The indications for anticoagulation are highly individualized and should be reviewed as the risks of thrombosis versus bleeding evolve as a patient approaches end-of-life.
  6. Seizures: Individuals with brain cancer or brain metastases, severe metabolic disturbances, pre-existing seizure disorders, or who are on medications that decrease the seizure threshold are at higher risk of seizures. As experiencing or witnessing seizures can be distressing for patients and their loved ones, anticipatory counselling and management can alleviate suffering. Seizure prophylaxis should be considered in patients at high risk of seizures or patients who have had prior seizures. For patients who do not have a reliable PO or IV route, SC phenobarbital is the prophylactic medication of choice. Though most seizures are self-limiting, prolonged seizures should be aborted with benzodiazepines.
  7. Pain Crises: This can be secondary to cancer and other comorbidities, or side effects of surgery, radiation, or chemotherapy. Pain crises are generally managed with opioids, adjuvant medications (ex. NSAIDs, ketamine, lidocaine), or with interventions done by interventional radiology or anaesthesia.
  8. Hypercalcemia: The most common metabolic disturbance seen with cancers that have bone involvement. Diagnosis is confirmed by a corrected calcium concentration of >2.8 mmol/L or ionized calcium of >1.40 mmol/L. Patients may exhibit weakness, fatigue, polydipsia, polyuria, nausea, vomiting, confusion, constipation, bone pain, or seizures. In an acute care setting, treatment involves IV rehydration, bisphosphonates, and calcitonin if severe hypercalcemia is present. In the end-of-life setting, blood work is not typically performed, but symptoms of hypercalcemia can be managed supportively.

More information on these conditions and their respective management plans is found in the Cancer Complications and Emergencies and Pain Management modules at https://www.learnoncology.ca/modules 

Summary

When a person with an incurable cancer has functional decline due to disease progression, it is important for providers to identify their care needs and whether they need increased community supports. This decision is made based on the opinion of various healthcare providers engaged in the patient’s care, and a conversation should be had with the patient to identify their personal goals, determine the feasibility and safety of their home environment, and discuss legal issues if not addressed prior. Optimization of the at-home dying process involves both de-prescription of unnecessary medications and anticipatory prescribing of medications that can improve quality of life, along with referrals to multidisciplinary care team members. Finally, it is important for providers to be aware of the stages of dying and common oncologic emergencies.

Virtual Patient Case

Use your mouse to click through the slides and answer each question in the text box provided.
Note: This case can be completed on an iPad. To do this download the (free) Articulate Mobile Player for the iPad by clicking here.

References

What is Palliative Care

  1. Health Canada. Framework on palliative care in Canada [Internet]. Government of Canada; 2018 [cited 2026 Oct 5]. Available from: https://www.canada.ca/en/health-canada/services/health-care-system/reports-publications/palliative-care/framework-palliative-care-canada.html

How to Make the Decision for At-Home Palliative Care

  1. Health Canada. Palliative care: preparing and deciding [Internet]. Government of Canada; 2023 [cited 2026 Sep 28]. Available from: https://www.canada.ca/en/health-canada/services/health-services-benefits/palliative-care/preparing-deciding.html
  2. Sanders JJ, Temin S, Ghoshal A, Alesi ER, Ali ZV, Chauhan C, et al. Palliative care for patients with cancer: ASCO guideline update. J Clin Oncol. 2024;42(19):2336-57. doi:10.1200/JCO.24.00542

Managing Conversations about Palliative Care

  1. Ariadne Labs, Dana-Farber Cancer Institute. Serious illness conversation guide [Internet]. Boston (MA): Ariadne Labs; 2015 [revised 2018 Feb; cited 2026 Sep 30]. Available from: https://www.bccancer.bc.ca/new-patients-site/Documents/SeriousIllnessConversationGuideCard.pdf
  2. Hoskote M, Le G, Cherian R, Zeiger R, Sarkar U. Cancer patient perspectives on survivorship goals from the Smart Patients online community. Support Care Cancer. 2021;29(5):2375–84. doi:10.1007/s00520-020-05734-0

Evaluating the Home

  1. Canadian Virtual Hospice. Remaining at home: things to consider [Internet]. Canadian Virtual Hospice; 2023 [cited 2026 Sep 28]. Available from: https://www.virtualhospice.ca/en_US/Main+Site+Navigation/Home/Topics/Topics/Decisions/Remaining+at+home_+Things+to+consider.aspx
  2. National Coalition for Hospice and Palliative Care. Mental health in palliative care: addressing psychological and psychiatric needs [Internet]. National Coalition for Hospice and Palliative Care; 2025 Feb 23 [cited 2026 Sep 30]. Available from: https://www.nationalcoalitionhpc.org/mental-health-in-palliative-care-addressing-psychological-and-psychiatric-needs/
  3.  Employment and Social Development Canada. EI caregiving benefits [Internet]. Government of Canada; 2018 [updated 2026 Jun 2; cited 2026 Oct 11]. Available from: https://www.canada.ca/en/services/benefits/ei/caregiving.html

Advance Care Planning

  1. Landry T. Advance care planning in Canada: a patchwork of legal terms and practices [Internet]. Canadian Hospice Palliative Care Association; 2026 Apr 16 [cited 2026 Oct 11]. Available from: https://www.chpca.ca/blog/advance-care-planning-in-canada-a-patchwork-of-legal-terms-and-practices/

Anticipatory Prescribing

  1. National Clinical Guideline Centre (UK). Care of dying adults in the last days of life. London: National Institute for Health and Care Excellence (NICE); 2015. NICE Guideline No. 31. Chapter 10, Anticipatory prescribing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK356005/
  2. Bowers B, Antunes BCP, Etkind S, et al. Anticipatory prescribing in community end-of-life care: systematic review and narrative synthesis of the evidence since 2017. BMJ Support Palliat Care. 2024;13(e3):e612-e623. doi:10.1136/spcare-2022-004080
  3. Pastrana T, De Lima L, Dudgeon D, Voeuk A, Ahmed E, Radbruch L. Use of Essential Medicines for Pain Relief and Palliative Care: A Global Consensus Process. J Pain Symptom Manage. 2025;69(1):53-64. doi:10.1016/j.jpainsymman.2024.10.024
  4. Alikan B, Can G. Evidence-Based Nonpharmacological Symptom Management of Palliative Care in Advanced and Metastatic Cancer Patients: A Systematic Review. Florence Nightingale J Nurs. 2024;32(1):90-98. doi:10.5152/FNJN.2023.23043
  5. Coelho A, Parola V, Cardoso D, Bravo ME, Apóstolo J. Use of non-pharmacological interventions for comforting patients in palliative care: a scoping review. JBI Database System Rev Implement Rep. 2017;15(7):1867-1904. doi:10.11124/JBISRIR-2016-003204
  6. Medical Advisory Board. What are the non-pharmacological and pharmacological management strategies for patients requiring palliative care? [Internet]. Droracle.ai. 2025 Sept [cited 2026 Oct 5]. Available from: https://www.droracle.ai/articles/307645/what-are-the-non-pharmacological-and-pharmacological-management-strategies-for

The Role of De-Prescribing

  1.  Thompson J. Deprescribing in palliative care. Clin Med (Lond). 2019;19(4):311-4. doi:10.7861/clinmedicine.19-4-311
  2. Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M, et al. The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’. Support Care Cancer. 2015;23(1):71-8. doi:10.1007/s00520-014-2322-0

Interdisciplinary Care

  1. Feliciano DR, Reis-Pina P. Enhancing End-of-Life Care With Home-Based Palliative Interventions: A Systematic Review. J Pain Symptom Manage. 2024;68(5):e356-e372. doi:10.1016/j.jpainsymman.2024.07.005
  2. Freeman S. The Roles In A Multidisciplinary Palliative Care Team [Internet]. Medical and Aged Care Group. 2025 March [cited 2026 Oct 5]. Available from: https://www.maacg.com.au/information-centre/what-are-the-different-roles-in-palliative-care
  3. Eastern Health. Palliative End of Life Care [Internet]. 2023 March [cited 2026 Oct 5]. Available from: https://peolc.easternhealth.ca/about/the-palliative-care-team/
  4. Valentim FAC, Oliveira NMS, Alves VP, Capelas MLV. Understanding the role of home-based palliative care in supporting patient dignity: a scoping review. BMC Palliat Care. 2026;25(1):36. doi:10.1186/s12904-025-01884-2

Stages of Dying

  1. Ijaopo EO, Zaw KM, Ijaopo RO, Khawand-Azoulai M. A Review of Clinical Signs and Symptoms of Imminent End-of-Life in Individuals With Advanced Illness. Gerontol Geriatr Med. 2023;9:23337214231183243. Published 2023 Jun 26. doi:10.1177/23337214231183243
  2. Karunarathna I, De Alvis K, Gunawardana K, Rajapaksha S, Warnakulasooriya A, Athulgama P, Dius S. Understanding the stages of dying from diagnosis to death [Internet]. Understanding the Stages of Dying From Diagnosis to Death; 2025 Feb. ISBN: 978-624-93721-0-8. Available from: https://www.researchgate.net/publication/388875495_Understanding_the_Stages_of_Dying_From_Diagnosis_to_Death

Palliative Emergencies

  1. Noble S. Emergencies in Palliative Care. Medicine. 2020; 48(1): 33-36. doi: 10.1016/j.mpmed.2019.10.011
  2. Krakauer EL, Rajagopal MR. Palliative care emergencies. In: Krakauer EL, editor. Clinical manual of palliative care for any setting: toward universal contextually-adapted access [Internet]. New York: Oxford University Press; 2025. Chapter 6. Available from: https://doi.org/10.1093/med/9780197755617.003.0006

Whiteboard Videos

Coming soon